InvestorsHub Logo
Followers 33
Posts 2841
Boards Moderated 2
Alias Born 10/24/2015

Re: None

Tuesday, 04/04/2023 4:39:09 PM

Tuesday, April 04, 2023 4:39:09 PM

Post# of 408
It makes little sense for them to waste resources on CD19 and BCMA-targeted CAR-T's considering just how crowded each space is. As for IL-12, it failed in multiple indications https://www.prnewswire.com/news-releases/precigen-regains-exclusive-rights-to-proven-car-t-targets-cd19-and-bcma-to-enable-unencumbered-development-and-commercialization-of-ultracar-t-301788820.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PGEN News